Old Web
English
Sign In
Acemap
>
authorDetail
>
Mathilde Kaper
Mathilde Kaper
Center for Global Development
Urology
Medicine
Overactive bladder
Mirabegron
Underactive bladder
6
Papers
85
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Symptoms and Signs to distinguish Detrusor Underactivity from Mixed Detrusor Underactivity and Bladder Outlet Obstruction in Male Patients
2016
Andrew Gammie
Satoshi Yoshida
Achim Steup
Mathilde Kaper
Caroline Dorrepaal
Ton Kos
P. Abrams
Show All
Source
Cite
Save
Citations (0)
Flow time and voiding time – definitions and use in identifying detrusor underactivity
2016
Neurourology and Urodynamics
Andrew Gammie
Satoshi Yoshida
Achim Steup
Mathilde Kaper
Caroline Dorrepaal
Ton Kos
Paul Abrams
Show All
Source
Cite
Save
Citations (1)
The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial
2015
Therapeutic Advances in Urology
Jose E. Batista
Heinz Kölbl
Sender Herschorn
Tomasz Rechberger
Javier Cambronero
Halaska M
Alex Coppell
Mathilde Kaper
Moses Huang
Emad Siddiqui
Show All
Source
Cite
Save
Citations (46)
Safety and efficacy of mirabegron add-on treatment to solifenacin in incontinent OAB subjects with an inadequate response to initial 4-week solifenacin monotherapy
2015
Neurourology and Urodynamics
Marcus J. Drake
Ahmet Adil Esen
Stavros Athanasiou
Claire Herholdt
Mathilde Kaper
Tahir Saleem
Moses Huang
Emad Siddiqui
Scott MacDiarmid
Show All
Source
Cite
Save
Citations (0)
1